Chronic Pain Comorbidities in Diabetes Management

Chronic pain commonly co-occurs with diabetes, spanning neuropathic and musculoskeletal syndromes that complicate self-care and glycaemic control. Patients with type 1 or type 2 diabetes frequently report persistent pain in the spine, joints and extremities, often driven by peripheral neuropathy, vascular insufficiency, pro-inflammatory states and mechanical overload. This confluence of factors amplifies functional limitations, disrupts daily activities and undermines quality of life, while depressive symptoms and sleep disturbances further exacerbate pain perception. Effective management requires early identification of pain comorbidities, integration of interdisciplinary therapies and tailored adjustments to pharmacological and rehabilitative regimens.

From a global perspective, chronic pain imposes substantial health-care and economic burdens on individuals and systems alike. Addressing pain in people with diabetes not only enhances mobility and mental well-being but also supports more consistent physical activity and improved insulin sensitivity. Advances in understanding the mechanistic links—such as small-fibre neuropathy, microvascular changes and metabolic inflammation—are guiding innovative approaches to pain modulation and integrated diabetes care.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Chronic Pain Comorbidities in Diabetes Management publication trend

The graph below shows the total number of articles in chronic pain comorbidities in diabetes management across all publications each year (not limited to Nature Index journals).

Technical terms

Neuropathic pain: Pain arising from damage to or dysfunction of somatosensory nerves, often presenting as burning, tingling or electric-like sensations.

Hyperglycaemia: A state of elevated blood glucose concentration, frequently observed in diabetes, that contributes to vascular and neural injury.

Glycaemic control: The management of blood glucose levels to within target ranges, typically assessed by metrics such as HbA1c.

Comorbidity: The co-existence of two or more chronic conditions in the same individual, each of which may interact to affect outcomes.

References

1. Prevalence and consequences of musculoskeletal pain in the upper and lower extremities: A cross-sectional analysis of patients with type 1 and type 2 diabetes in Denmark. Primary Care Diabetes (2023).
2. Prevalence and consequences of spinal pain among people with type 1 and type 2 diabetes mellitus in Denmark. European Spine Journal (2023).
3. Dyslipidemia Is Positively Associated with Chronic Low Back Pain in Korean Women: Korean National Health and Nutrition Examination Survey 2010–2012. Healthcare (2024).